BONE-MARROW STROMAL CELL CHANGES IN HEMATOLOGICAL MALIGNANCIES

被引:35
|
作者
DILLY, SA
JAGGER, CJ
机构
[1] Department of Histopathology, St George's Hospital, Medical School, London SW17 0RE, Cranmer Terrace
关键词
D O I
10.1136/jcp.43.11.942
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Stromal cell numbers from subjects with no haematological disease and those with acute myeloid leukaemia (AML), chronic granulocytic leukaemia (CGL), acute lymphatic leukaemia (ALL) and non-Hodgkin's lymphoma (NHL) were compared to determine their role in malignancy. Frozen sections of trephine biopsy specimens from iliac crests were stained for endogenous alkaline phosphatase activity, endogenous acid phosphatase activity, and, using immunocytochemical methods, for endothelial cells (anti-factor-VIII related antigen) and macrophages and related cells (EBM/11). In granulocytic malignancies, whether acute or chronic, alkaline phosphatase positive reticulum cells (AL-RC) and vascular endothelial cells were generally increased. In lymphoid malignancies, the numbers of AL-RC were generally reduced. Numbers of vascular endothelial cells seemed to be normal in ALL but reduced in foci of NHL. Macrophages are numerous in normal marrow, and their numbers seemed to be normal in granulocytic lesions but were more variable and sometimes reduced in ALL and NHL. Lymphoid malignancies, therefore, have a destructive effect on some stromal elements; granulocytic malignancies are associated with normal or increased numbers of stromal cells. A possible consequence of depleted stromal cells might be slower reconstitution of normal haemopoiesis after treatment. The large numbers in granulocytic malignancies raises the possibility of synergistic stimulation between stromal and neoplastic cells.
引用
收藏
页码:942 / 946
页数:5
相关论文
共 50 条
  • [1] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES
    GORIN, NC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 : S5 - S14
  • [2] THE SIGNIFICANCE OF BONE-MARROW EVALUATION IN HEMATOLOGICAL MALIGNANCIES
    DOHNER, H
    EHRHARDT, R
    RADIOLOGE, 1992, 32 (10): : 481 - 484
  • [3] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES
    GORIN, NC
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (01): : 1 - 9
  • [4] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES
    GAHRTON, G
    GRATWOHL, A
    ERNST, P
    HERMANS, J
    LYKLEMA, A
    ZWAAN, FE
    BONE MARROW TRANSPLANTATION, 1989, 4 : 4 - 6
  • [5] AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    MELONI, G
    DEFABRITIIS, P
    PULSONI, A
    SANDRELLI, A
    GIARNIERI, V
    MOLETI, ML
    MANDELLI, F
    BONE MARROW TRANSPLANTATION, 1988, 3 : 103 - 103
  • [6] EPIDEMIOLOGY OF INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND IN BONE-MARROW TRANSPLANTS
    DEPAUW, BE
    HOOGKAMPKORSTANJE, MAA
    BAILLIERES CLINICAL INFECTIOUS DISEASES, 1994, 1 (03): : 391 - 414
  • [7] BONE-MARROW TRANSPLANTATION FOR TREATMENT OF HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS
    FROMMHOLD, H
    NIEDERWIESER, D
    HUBER, C
    MARGREITER, R
    URL, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1987, 163 (04) : 244 - 244
  • [8] 2ND BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
    HASHIMOTO, S
    NAKASEKO, T
    ASAI, T
    NAKAMURA, H
    OH, H
    YOSHIDA, S
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 715 - 715
  • [9] BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS
    NIEDERWIESER, D
    AULITZKY, W
    FROMMHOLD, H
    SCHONITZER, D
    URL, M
    ALLERBERGER, F
    WIEGELE, J
    GRATWOHL, A
    BRAUNSTEINER, H
    HUBER, C
    WIENER KLINISCHE WOCHENSCHRIFT, 1987, 99 (02) : 49 - 53
  • [10] NUCLEOLAR IMMUNOFLUORESCENCE IN BONE-MARROW SPECIMENS OF HUMAN HEMATOLOGICAL MALIGNANCIES
    SMETANA, K
    BUSCH, RK
    HERMANSKY, F
    BUSCH, H
    BLUT, 1981, 42 (02): : 79 - 86